Evaluation of the Effect of Pramlintide on Satiety and Food Intake

NCT00042601 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions

DRUG: Pramlintide acetate
DRUG: Placebo

Sponsor

AstraZeneca